Randomized Registry Trials - efficient post market clinical follow-up for medical devices

In spite of advances in the treatment of cardiovascular disease, there remains a significant need for high-quality evidence for clinical practice given the rising prevalence worldwide. Next to the increase of regulatory requirements, poor screening-to-recruitment ratios, lack of patient engagement,...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Leuchter Matthias, Siewert Stefan, Stiehm Michael, Klar Ernst, Schmitz Klaus-Peter, Kaule Sebastian
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	De Gruyter 2023-09-01
Edice:	Current Directions in Biomedical Engineering
Témata:	medical device regulation post-market clinical follow-up registries regulatory affairs
On-line přístup:	https://doi.org/10.1515/cdbme-2023-1122
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!